FDA warns of benzocaine complications in teething gels

This just came in from American Dental Association News.  We at Seasons of Smiles Dental are doing all we can to get the word out. The U.S. Food and Drug Administration announced April 7 that it continues to receive reports of methemoglobinemia, a rare but serious blood disorder that is associated with pain relievers containing benzocaine, including teething gels. The agency says that methemoglobinemia has been reported with all strengths of benzocaine gels and liquids, including concentrations as low as 7.5 percent. The cases involving low concentration products were mainly in children ages 2 or younger who were treated with the benzocaine gel form for teething. The FDA is advising health care professionals to refer to the American Academy of … Continue reading →